Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma

NCT01333709 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Malignant Neoplasm
Rectal Carcinoma

Interventions

DRUG: Induction trichemotherapy - FOLFIRINOX regimen
OTHER: Early tumor response evaluation by MRI volumetry
RADIATION: Radiochemotherapy Cap 50
RADIATION: Radiochemotherapy Cap 60
PROCEDURE: Radical proctectomy with total mesorectal excision

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle